BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24098947)

  • 1. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
    Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
    BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
    Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
    PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.
    Samuel T; Fadlalla K; Gales DN; Putcha BD; Manne U
    BMC Cancer; 2014 Aug; 14():599. PubMed ID: 25134433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus-activated kinases and signal transducer and activator of transcription control tumor growth response to camptothecin in human colon cancer cells.
    Yun HJ; Kim SY; Kwon YY; Kim CH; Kang CM; Kim EJ
    Cancer Biol Ther; 2010 Aug; 10(4):354-61. PubMed ID: 20534983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.
    Huerta-Yepez S; Yoon NK; Hernandez-Cueto A; Mah V; Rivera-Pazos CM; Chatterjee D; Vega MI; Maresh EL; Horvath S; Chia D; Bonavida B; Goodglick L
    BMC Cancer; 2011 Jun; 11():259. PubMed ID: 21689459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of RKIP function by Helicobacter pylori in gastric cancer.
    Moen EL; Wen S; Anwar T; Cross-Knorr S; Brilliant K; Birnbaum F; Rahaman S; Sedivy JM; Moss SF; Chatterjee D
    PLoS One; 2012; 7(5):e37819. PubMed ID: 22662230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.
    Wei J; Ma L; Lai YH; Zhang R; Li H; Li C; Lin J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):63. PubMed ID: 30736824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
    Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
    Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.
    Maresch J; Birner P; Zakharinov M; Toumangelova-Uzeir K; Natchev S; Guentchev M
    Cancer; 2011 Jun; 117(11):2499-504. PubMed ID: 24048798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.
    Miyaki Y; Suzuki K; Koizumi K; Kato T; Saito M; Kamiyama H; Maeda T; Shibata K; Shiya N; Konishi F
    Int J Oncol; 2012 Jan; 40(1):217-26. PubMed ID: 21901246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
    Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
    Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.
    Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K
    Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
    Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
    Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer.
    Nisimova L; Wen S; Cross-Knorr S; Rogers AB; Moss SF; Chatterjee D
    Crit Rev Oncog; 2014; 19(6):469-81. PubMed ID: 25597356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
    Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
    Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
    Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
    Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3.
    Shen A; Chen Y; Hong F; Lin J; Wei L; Hong Z; Sferra TJ; Peng J
    Oncol Rep; 2012 Dec; 28(6):2125-30. PubMed ID: 23027374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.